BCL2 and lung carcinoma: Regarding the anticancer effect of MET and SIL, in this research, we investigate the synergistic effect of co-delivery MET and SIL loaded in PEGylated niosome to enhance their bioavailability and evaluate their effects on the expression of hTERT, BCL-2, and BAX genes in NSCLC type lung cancer cells.